Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06352775 · ClinicalTrials.gov registry record · NA

Calcium Carbonate on Labor Induction

A NA study of Pregnancy and Uterine Contraction, sponsored by Wake Forest University Health Sciences.

Active
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT06352775 is a NA study of Pregnancy and Uterine Contraction that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 250 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06352775, a NA study of Pregnancy and Uterine Contraction, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The investigators aim to evaluate the safety and efficacy of administering calcium carbonate to laboring participants undergoing labor inductions. The investigators hypothesize that calcium carbonate is a low-risk preventative measure to decrease oxytocin induction time and dosage, decrease the rate of labor dystocia, decrease the rate of cesarean deliveries, and demonstrate no differences in maternal or neonatal safety outcomes.

Interventions

  • DIETARY_SUPPLEMENT Calcium Carbonate

Study Locations (1)

Wisconsin

  • Aurora Sinai Medical Center - Milwaukee

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-06-01
Est. Completion 2026-12-30
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT06352775

The ClinicalTrials.gov registry entry for NCT06352775 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (71% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Calcium Carbonate is the first listed.

NCT06352775 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06352775 about?

NCT06352775 is a clinical study titled "Calcium Carbonate on Labor Induction". The investigators aim to evaluate the safety and efficacy of administering calcium carbonate to laboring participants undergoing labor inductions. The investigators hypothesize that calcium carbonate is a low-risk preventative measure to decrease oxytocin induction time and dosage, decrease the rate...

What is the current status of trial NCT06352775?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-06-01. Estimated completion is 2026-12-30.

What conditions does trial NCT06352775 study?

This clinical trial studies the following conditions: Pregnancy, Uterine Contraction.

What interventions are being tested in trial NCT06352775?

The interventions under investigation include: Calcium Carbonate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06352775?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06352775 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.